ALEXION PHARMACEUTICALS INC.

In News

Alexion Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 29, 2026

AstraZeneca highlights rare diseases in $80bn revenue push - Financial Times

Financial Times - Jul 19, 2026

Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter - Yahoo Finance

Yahoo Finance - Jul 29, 2026

Delphine Caroff Appointed Vice President Corporate Affairs at Alexion Pharmaceuticals - hrtoday.in

hrtoday.in - Sep 26, 2026

Genentech, two other drug companies object to Lilly's planned buyout of bankrupt Sangamo's tech - The Business Journals

The Business Journals - Aug 18, 2026

Massachusetts Federal Court Reinforces Chapter 93A Causation Requirement and Rejects Trade Secret Misuse Theory in Pharmaceutical Case - The National Law Review

The National Law Review - Jun 02, 2026

Xencor Announces Change to Ultomiris® Royalty Revenue Forecast - Business Wire

Business Wire - Mar 04, 2026

Ex-employees get jury trial on ‘age-biased’ rehiring program - Massachusetts Lawyers Weekly

Massachusetts Lawyers Weekly - Apr 07, 2026

Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies - AstraZeneca

AstraZeneca - Jul 28, 2023

Document - SEC.gov

SEC.gov - Feb 04, 2021

AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases - Fierce Pharma

Fierce Pharma - Jul 21, 2021

Geographic Atrophy Market to Surge Significantly During the - GlobeNewswire

GlobeNewswire - Dec 01, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment